Bookmarks
CCU001: Investigating the effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 outcomes
Safe People
Organisation name
University of Bristol
Organisation sector
Academic Institute
Applicant name(s)
Jonathan Sterne
Sub-licence arrangements (if any)?
No
Safe Projects
Project ID
CCU001
Lay summary
ACE inhibitors and angiotensin receptor blockers are drugs that are commonly used to lower high blood pressure. These drugs may affect the ability of the coronavirus to enter cells of the body and cause COVID-19. We plan to investigate whether use of these drugs affects people’s chance of becoming infected or unwell with COVID-19. We will conduct carefully planned analyses of data from millions of people’s healthcare records. These records provide information about people’s health and prescribed medications, as well as on which people became infected or unwell with COVID-19. People who take drugs to lower their blood pressure are more likely to have other risk factors for becoming infected or unwell with COVID-19. Our analysis methods will account for these risk factors, to work out whether any change in risk is due to the blood pressure lowering drugs themselves. Our results will help to inform the way that blood pressure lowering drugs are used in the future, particularly while the pandemic continues.
Public benefit statement
Our results will help to inform the way that blood pressure lowering drugs are used in the future, particularly while the pandemic continues.
Latest approval date
30/10/2020
Safe Data
Dataset(s) name
Data sensitivity level
De-Personalised
Safe Setting
Access type
TRE